The next biggest markets for CROs Part 1: Argentina

Argentina   After going through an economic crisis 10 years ago, Argentina is emerging as a pharmaceutical and CRO dynamo, according to a study from GBI Research.Valued at $49.4 million in terms of revenue in 2010 (a small but growing figure), the Argentine clinical trial market is forecast to grow at a compound annual growth rate of 9% between 2010 …